Strictly for Research Purposes · Not for Human Consumption · 99%+ Purity Guaranteed
Research & Development
Precision engineering at the molecular level. Discover the rigorous methodologies behind our pharmaceutical-grade research compounds.
Fundamentals
Peptides are short chains of amino acids — typically between 2 and 50 residues — that function as highly specific signaling molecules within biological systems. Unlike larger proteins, their compact structure allows them to bind with exceptional selectivity to targeted receptors, making them invaluable tools in cellular in-vitro research.
In laboratory models, synthetic peptides serve as research probes for exploring pathways involved in tissue repair, metabolic regulation, and cellular communication. Their sequence-specific nature means that even a single amino acid substitution can fundamentally alter binding affinity and downstream signaling outcomes.
AminoVita compounds are synthesized with sequence fidelity as a non-negotiable standard — every residue confirmed by Mass Spectrometry before a batch is approved for distribution.
Amino Acid Precision
Sequence-verified, residue by residue
Synthesis Methodology
Solid-Phase Peptide Synthesis is the industry-benchmark method for producing high-purity synthetic peptides. The process anchors the first amino acid to an insoluble resin support, then sequentially adds each subsequent residue in a precisely controlled, stepwise fashion using Fmoc chemistry.
Between each coupling cycle, unreacted sites are capped to prevent deletion sequences, and protecting groups are removed under controlled conditions. This systematic approach dramatically reduces side reactions and truncated sequences that would compromise the integrity of the final compound.
The result is an ultra-high purity peptide — consistently exceeding 99% by HPLC — with the molecular fidelity required for reproducible in-vitro research outcomes.
Post-Synthesis Processing
Synthesis is only half the equation. Every batch undergoes a rigorous stabilisation process before it reaches your laboratory.
State-of-the-art freeze-drying technology removes residual moisture from the peptide matrix without exposing the compound to elevated temperatures. This preserves delicate peptide bonds and secondary structures that heat-based drying would irreversibly denature.
The lyophilization process produces a compact, uniform powder puck that is inherently resistant to oxidative and hydrolytic degradation. In this dry state, the peptide remains chemically stable across a broad range of ambient storage conditions, extending its viable research shelf-life significantly.
Each vial is sealed under nitrogen, packaged with cold-chain compliant materials, and shipped with monitored temperature controls. Upon arrival, reconstitution with bacteriostatic water in the laboratory environment restores full bioactivity, ensuring maximum efficacy for your research protocol.
From Sequence to Vial
01
Target peptide sequences are selected based on published literature and validated in-vitro activity profiles.
02
Automated Fmoc SPPS builds the chain residue by residue on a solid resin support under inert conditions.
03
Every batch is tested by an independent ISO-accredited laboratory. Only batches exceeding 99% purity are released.
04
Freeze-dried under nitrogen, sealed, and dispatched with full cold-chain compliance and a published COA.
Access the full batch testing database — including HPLC chromatograms and MS spectra — for every compound we supply.
